GAS2 and chronic myelogenous leukemia, BCR-ABL1 positive: For chronic myeloid leukaemia (CML), Huang et al provided evidence that the high expression level of GAS2 is associated with increased β‐catenin‐dependent survivin expression, resulting in a Fas‐induced apoptosis resistance status in Bcr‐Abl‐positive or ICSBP‐knockout myeloid progenitor cells.47